title: Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder.
abstract: A retrospective review of the psychiatric records of nine patients with posttraumatic stress disorder (PTSD) was conducted to determine the efficacy of cyproheptadine in relieving nightmares. The treatment dose was 4 to 12 mg at bedtime. The response varied from complete remission to a decrease in the intensity and frequency of nightmares.
authors.affiliation: Department of Psychiatry, Olean General Hospital, NY, USA.
authors.forename: S
authors.initials: S
authors.lastname: Gupta
authors.forename: A
authors.initials: A
authors.lastname: Popli
authors.forename: E
authors.initials: E
authors.lastname: Bathurst
authors.forename: L
authors.initials: L
authors.lastname: Hennig
authors.forename: T
authors.initials: T
authors.lastname: Droney
authors.forename: P
authors.initials: P
authors.lastname: Keller
mesh_terms: D000328:Adult; D003533:Cyproheptadine / Q000627:therapeutic use*; D004325:Dreams / Q000187:drug effects*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D012702:Serotonin Antagonists; D003533:Cyproheptadine